Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
RYOIX vs FBIOX
Shared holdings
48
RYOIX covered by FBIOX
45.62%
FBIOX covered by RYOIX
45.62%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
RYOIX (March 31, 2026)
| Security | Weight | |
|---|---|---|
| ABBVIE INC | 7.46% | |
| AMGEN INC | 5.28% | |
| GILEAD SCIENCES INC | 5.00% | |
| VERTEX PHARMACEUTICALS INC | 4.04% | |
| REGENERON PHARMACEUTICALS INC | 3.59% | |
| ALNYLAM PHARMACEUTICALS INC | 2.63% | |
| INSMED INC | 2.48% | |
| BEONE MEDICINES LTD ADR | 2.31% | |
| NATERA INC | 2.11% | |
| UNITED THERAPEUTICS CORP DEL | 2.09% | |
| BIOGEN INC | 2.03% | |
| ROYALTY PHARMA PLC | 2.00% | |
| ILLUMINA INC | 1.75% | |
| REVOLUTION MEDICINES INC | 1.71% | |
| MODERNA INC | 1.66% | |
| ASTRAZENECA PLC | 1.62% | |
| ARGENX SE SPONSORED ADR | 1.62% | |
| INCYTE CORP | 1.57% | |
| VIATRIS INC | 1.51% | |
| BRIDGEBIO PHARMA INC | 1.48% | |
| ALKERMES PLC | 1.48% | |
| JAZZ PHARMA PLC | 1.48% | |
| NEUROCRINE BIOSCIENCES INC | 1.43% | |
| GUARDANT HEALTH INC | 1.42% | |
| ROIVANT SCIENCES LTD | 1.41% | |
| IONIS PHARMACEUTICALS INC | 1.40% | |
| EXELIXIS INC | 1.30% | |
| MEDPACE HOLDINGS INC | 1.27% | |
| BIOMARIN PHARMACEUTICAL INC | 1.26% | |
| APELLIS PHARMACEUTICALS INC | 1.24% | |
| ARROWHEAD PHARMACEUTICALS INC | 1.24% | |
| CYTOKINETICS INC | 1.19% | |
| VAXCYTE INC | 1.15% | |
| CRISPR THERAPEUTICS AG | 1.14% | |
| HALOZYME THERAPEUTICS INC | 1.10% | |
| BIONTECH SE ADR | 1.07% | |
| AXSOME THERAPEUTICS INC | 1.03% | |
| Ascendis Pharma A/S | 1.02% | |
| COGENT BIOSCIENCES INC | 1.00% | |
| ARCELLX INC | 1.00% | |
| TG THERAPEUTICS INC | 0.97% | |
| PTC THERAPEUTICS INC | 0.96% | |
| SCHOLAR ROCK HOLDING CORP | 0.95% | |
| MADRIGAL PHARMACEUTICALS INC | 0.91% | |
| MIRUM PHARMACEUTICALS INC | 0.90% | |
| PROTAGONIST THERAPEUTICS INC | 0.88% | |
| AMICUS THERAPEUTICS INC | 0.82% | |
| RHYTHM PHARMACEUTICALS INC | 0.79% | |
| APOGEE THERAPEUTICS INC | 0.76% | |
| KYMERA THERAPEUTICS INC | 0.73% |
FBIOX (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| ABBVIE INC | 12.90% | |
| KRYSTAL BIOTECH INC | 9.08% | |
| GILEAD SCIENCES INC | 8.55% | |
| AMGEN INC | 8.13% | |
| ALNYLAM PHARMACEUTICALS INC | 3.01% | |
| Fidelity Securities Lending Cash Central Fund | 2.48% | |
| PRAXIS PRECISION MEDICINES INC | 2.40% | |
| Ascendis Pharma A/S | 2.38% | |
| INSMED INC | 2.21% | |
| UCB SA | 2.12% | |
| ARGENX SE SPONSORED ADR | 2.09% | |
| REGENERON PHARMACEUTICALS INC | 1.44% | |
| MODERNA INC | 1.40% | |
| SCHOLAR ROCK HOLDING CORP | 1.33% | |
| NATERA INC | 1.26% | |
| COGENT BIOSCIENCES INC | 1.20% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 1.07% | |
| BIOGEN INC | 1.05% | |
| ROIVANT SCIENCES LTD | 1.04% | |
| VERTEX PHARMACEUTICALS INC | 1.02% | |
| BRIDGEBIO PHARMA INC | 0.86% | |
| PROTAGONIST THERAPEUTICS INC | 0.85% | |
| IMMUNOME INC | 0.85% | |
| TERNS PHARMACEUTICALS INC | 0.83% | |
| REVOLUTION MEDICINES INC | 0.82% | |
| KYMERA THERAPEUTICS INC | 0.77% | |
| IONIS PHARMACEUTICALS INC | 0.70% | |
| ARRIVENT BIOPHARMA INC | 0.70% | |
| CRINETICS PHARMACEUTICALS INC | 0.69% | |
| Abivax SA SPONSORED ADS | 0.67% | |
| STRUCTURE THERAPEUTICS INC ADR | 0.65% | |
| DISC MEDICINE INC | 0.65% | |
| GALDERMA GROUP A | 0.64% | |
| ZEALAND PHARMA A | 0.62% | |
| CYTOKINETICS INC | 0.57% | |
| CANDEL THERAPEUTICS INC | 0.57% | |
| BIO AB2 HOLDINGS LLC ARC | 0.54% | |
| VIRIDIAN THERAPEUTICS INC | 0.54% | |
| VAXCYTE INC | 0.53% | |
| STOKE THERAPEUTICS INC | 0.53% | |
| NUVALENT INC-A | 0.51% | |
| APOGEE THERAPEUTICS INC | 0.50% | |
| TREVI THERAPEUTICS INC | 0.50% | |
| ANNEXON INC | 0.48% | |
| ARROWHEAD PHARMACEUTICALS INC | 0.47% | |
| DIANTHUS THERAPEUTICS INC | 0.43% | |
| VOR BIOPHARMA INC | 0.43% | |
| EDGEWISE THERAPEUTICS INC | 0.43% | |
| UNITED THERAPEUTICS CORP DEL | 0.41% | |
| INTELLIA THERAPEUTICS INC | 0.40% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.